PetMed Express (NASDAQ:PETS) Shares Pass Above Two Hundred Day Moving Average - Here's What Happened

Shares of PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $4.15 and traded as high as $4.82. PetMed Express shares last traded at $4.77, with a volume of 131,466 shares traded.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of PetMed Express from a "hold" rating to a "buy" rating in a research report on Tuesday, November 12th.

PetMed Express Trading Down 0.2 %

The firm has a market cap of $98.56 million, a P/E ratio of -79.50 and a beta of 0.69. The business has a 50-day moving average price of $5.05 and a 200-day moving average price of $4.15.

PetMed Express (NASDAQ:PETS - Get Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.17. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. The company had revenue of $59.57 million for the quarter, compared to analysts' expectations of $66.02 million. On average, equities analysts anticipate that PetMed Express, Inc. will post 0.24 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Leslie C.G. Campbell acquired 15,000 shares of the business's stock in a transaction dated Wednesday, December 4th. The shares were purchased at an average price of $5.38 per share, with a total value of $80,700.00. Following the transaction, the director now directly owns 70,000 shares in the company, valued at approximately $376,600. This represents a 27.27 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On PetMed Express

Several institutional investors have recently bought and sold shares of PETS. Point72 DIFC Ltd acquired a new stake in PetMed Express in the second quarter worth about $34,000. Marshall Wace LLP acquired a new stake in shares of PetMed Express during the second quarter worth $46,000. Independent Advisor Alliance purchased a new stake in shares of PetMed Express during the third quarter valued at $106,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of PetMed Express in the 2nd quarter valued at $135,000. Finally, Sei Investments Co. raised its stake in PetMed Express by 8.3% in the 2nd quarter. Sei Investments Co. now owns 44,220 shares of the company's stock worth $179,000 after acquiring an additional 3,400 shares during the last quarter. 73.33% of the stock is currently owned by institutional investors and hedge funds.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.